Trial Profile
Trans-catheter Arterial p53-gene-embolization Using Gelatin Sponge Particles in Treatment of Patients With Advanced Hepatocellular Carcinoma: A Phase II Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Contusugene ladenovec (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Shenzhen SiBiono GeneTech
- 29 Jul 2015 New trial record